de Jong EMGJ - Search Results

1

Blood-Based Immune Profiling Combined with Machine Learning Discriminates Psoriatic Arthritis from Psoriasis Patients.

Mulder MLM, He X, van den Reek JMPA, Urbano PCM, Kaffa C, Wang X, van Cranenbroek B, van Rijssen E, van den Hoogen FHJ, Joosten I, Alkema W, de Jong EMGJ, Smeets RL, Wenink MH, Koenen HJPM. Mulder MLM, et al. Among authors: de jong emgj. Int J Mol Sci. 2021 Oct 12;22(20):10990. doi: 10.3390/ijms222010990. Int J Mol Sci. 2021. PMID: 34681660 Free PMC article.

2

Clinical aspects of systemic and localized scleroderma.

van den Hoogen FH, de Jong EM. van den Hoogen FH, et al. Curr Opin Rheumatol. 1995 Nov;7(6):546-50. doi: 10.1097/00002281-199511000-00014. Curr Opin Rheumatol. 1995. PMID: 8579977 Review.

3

Reliability of two methods to assess morphea: skin scoring and the use of a durometer.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):793-6. doi: 10.1016/s0190-9622(97)70121-x. J Am Acad Dermatol. 1997. PMID: 9366834 Free article. Clinical Trial. No abstract available.

4

Low-dose methotrexate in the treatment of widespread morphea.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):220-5. doi: 10.1016/s0190-9622(98)70079-9. J Am Acad Dermatol. 1998. PMID: 9704833 Clinical Trial.

5

Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.

Seyger MM, van Bruggen MC, Hardeman HK, van den Hoogen FH, Berden JH, van den Born J, De Jong EM. Seyger MM, et al. Acta Derm Venereol. 1998 Sep;78(5):326-30. doi: 10.1080/000155598442971. Acta Derm Venereol. 1998. PMID: 9779246 Free article.

6

Systemic sclerosis: new insights in autoimmunity.

Kaal SE, van Den Hoogen FH, de Jong EM, Viëtor HE. Kaal SE, et al. Proc Soc Exp Biol Med. 1999 Oct;222(1):1-8. doi: 10.1111/j.1525-1373.1999.09991.x. Proc Soc Exp Biol Med. 1999. PMID: 10510242 Review.

7

Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.

den Broeder AA, de Jong E, Franssen MJ, Jeurissen ME, Flendrie M, van den Hoogen FH. den Broeder AA, et al. Ann Rheum Dis. 2006 Jun;65(6):760-2. doi: 10.1136/ard.2004.033662. Epub 2005 Nov 3. Ann Rheum Dis. 2006. PMID: 16269431 Free PMC article.

8

Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.

Kroft EB, Creemers MC, van den Hoogen FH, Boezeman JB, de Jong EM. Kroft EB, et al. Br J Dermatol. 2009 May;160(5):1075-82. doi: 10.1111/j.1365-2133.2008.09017.x. Epub 2009 Feb 4. Br J Dermatol. 2009. PMID: 19210503

9

Analysis of 4-year Dutch reimbursement application data of biological therapies for psoriatic arthritis.

Driessen RJ, de Jong EM, Salemink GW, Bürer JH, van de Kerkhof PC, van den Hoogen FH. Driessen RJ, et al. Rheumatology (Oxford). 2010 Mar;49(3):588-91. doi: 10.1093/rheumatology/kep428. Epub 2009 Dec 29. Rheumatology (Oxford). 2010. PMID: 20040525

10

Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C*06.

Bergboer JG, Oostveen AM, de Jager ME, den Heijer M, Joosten I, van de Kerkhof PC, Zeeuwen PL, de Jong EM, Schalkwijk J, Seyger MM. Bergboer JG, et al. Br J Dermatol. 2012 Oct;167(4):922-5. doi: 10.1111/j.1365-2133.2012.10992.x. Br J Dermatol. 2012. PMID: 22512642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page